PRO-BANTHINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pro-banthine, and what generic alternatives are available?
Pro-banthine is a drug marketed by Gd Searle Llc and Shire and is included in two NDAs.
The generic ingredient in PRO-BANTHINE is propantheline bromide. There are seven drug master file entries for this compound. Additional details are available on the propantheline bromide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRO-BANTHINE?
- What are the global sales for PRO-BANTHINE?
- What is Average Wholesale Price for PRO-BANTHINE?
Summary for PRO-BANTHINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Patent Applications: | 2,171 |
| DailyMed Link: | PRO-BANTHINE at DailyMed |
US Patents and Regulatory Information for PRO-BANTHINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gd Searle Llc | PRO-BANTHINE | propantheline bromide | INJECTABLE;INJECTION | 008843-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Shire | PRO-BANTHINE | propantheline bromide | TABLET;ORAL | 008732-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Shire | PRO-BANTHINE | propantheline bromide | TABLET;ORAL | 008732-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
